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bstract
Lesch-Nyhan disease is caused by a deficiency of the purine salvage enzyme, hypoxanthine phosphoribosyl transferase (HPRT). The link between
PRT deficiency and the neuropsychiatric symptoms is unknown. In rat B103 neuroblastoma cell membranes and mouse Neuro2a neuroblastoma
ell membranes, nucleoside 5′-triphosphatase (NTPase) activity is substantially reduced, whereas in fibroblast membranes from HPRT knock-out
ice, NTPase activity is increased. Candidate genes for these NTPase activity changes are ecto-nucleoside 5′-triphosphate diphosphohydrolases
NTPDases). Therefore, we studied expression of NTPDases in B103 cells, Neuro2a cells and skin fibroblasts by reverse transcriptase polymerase
hain reaction and restriction enzyme digestion of amplified cDNA fragments. In B103 cells, expression of NTPDases 1, 3 and 6 decreased, whereas
xpression of NTPDases 4 and 5 increased in HPRT deficiency. In Neuro2a cells, expression of NTPDases 3–6 increased in HPRT deficiency.
n fibroblasts, NTPDase 3 expression decreased, and expression of NTPDases 4–6 increased in HPRT deficiency. Collectively, there are complex
ecreases and increases in NTPDase isoform expression in HPRT deficiency that depend on the specific cell type and species studied. These
hanges in NTPDase expression may reflect an (insufficient) attempt of cells to compensate for the changes in nucleotide metabolism caused by
PRT deficiency.
2007 Elsevier Ireland Ltd. All rights reserved.
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esch-Nyhan disease (LND) is caused by a defect of hypox-
nthine phosphoribosyl transferase (HPRT) [10,6]. Clinical
ymptoms of LND are hyperuricemia, gouty arthritis, men-
al retardation, dystonia, spasticity, delayed motor development
nd a compulsive form of self-injurious behavior. The link
etween HPRT deficiency and the neuropsychiatric symptoms
s unknown. To study the biochemical basis for the neuropsy-
hiatric symptoms in LND, a HPRT knock-out mouse was
enerated [15]. Similar to LND patients, there are abnormali-
ies in dopaminergic neurotransmission in the HPRT knock-out
ouse [7,16]. In addition, several HPRT-deficient cell lines
Abbreviations: HPRT, hypoxanthine phosphoribosyl transferase; LND,
esch-Nyhan disease; NTP, nucleoside 5′-triphosphate; NTPase, nucleoside 5′-
riphosphatase; NTPDase, ecto-nucleoside 5′-triphosphate diphosphohydrolase;
T-PCR, reverse transcriptase polymerase chain reaction
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ncluding primary human skin fibroblasts, immortalized mouse
kin fibroblasts, mouse Neuro2a neuroblastoma cells and rat
103 neuroblastoma are used as biochemical models for LND
18,2,4,12,11]. In a recent study [11] we showed that nucleo-
ide 5′-triphosphatase (NTPase) activity in B103- and Neuro2a
ell membranes is reduced in HPRT-deficiency. In contrast, in
ouse skin fibroblast membranes, NTPase activity is increased
n HPRT deficiency. Thus, altered NTPase activity is a hall-
ark of HPRT deficiency and these changes are cell type- and
pecies-specific. However, it is very difficult to reveal the molec-
lar identity of the NTPase(s) in complex systems by measuring
nzyme activity. Specifically, analysis of enzyme activity with
arious substrates and inhibitors revealed monophasic kinetics
n control- and HPRT-deficient cells [11], suggesting that a sin-
le protein species accounts for the observed activity. However,
mall contributions of multiple protein species to the overall
nzyme kinetics may be missed in such biochemical analysis.
likely candidate gene family responsible for the alterations in
TPase activity in HPRT-deficiency are the ecto-nucleoside 5′-
riphosphate diphosphohydrolases (NTPDases) [17,13]. In fact,
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here is evidence that these enzymes play a role in neuronal
evelopment, which is disturbed in LND, and in the regula-
ion of signal transduction mediated via purinergic receptors. It
s also emerging that various NTPDase isoforms play distinct
oles in neuronal development and signal transduction [17,13].
herefore, we examined expression of NTPDases 1–6 in B103
ells, Neuro2a cells and skin fibroblasts by reverse transcrip-
ase polymerase chain reaction (RT-PCR) and restriction enzyme
igestion of amplified cDNA fragments.
Immortalized mouse skin fibroblasts from control mice and
PRT knock-out mice, rat B-103 control and HPRT-deficient
103 cells and mouse Neuro2a control and HPRT-deficient
euro2a cells were cultured and passaged under the conditions
escribed in [11]. HPRT-deficiency of cell clones used for exper-
ments was confirmed with the 6-thioguanine resistance test [11].
ell membranes were prepared as described [11].
RT-PCR analysis was performed similarly as the previously
escribed protocol [14]. In brief, confluent cells from a 25 cm2
ulture were harvested with a cell scraper, and mRNA was iso-
ated with the RNeasy kit from Qiagen (Hilden, Germany) and
reated with RNase-free DNase. mRNA concentration was deter-
ined photometrically and reverse-transcribed using the First
trand cDNA synthesis kit from GE Healthcare (Munich, Ger-
any) and oligo-dT as primer. cDNA was stored at −80 ◦Cntil PCR amplification. Primers were chosen in such a way
hat for each NTPDase, fragments of unique length were gener-
ted. Moreover, the primers were designed to include an internal
iagnostic restriction enzyme site within the amplified sequence,
t
N
o
e
able 1
verview on primers, National Center for Biotechnology GenBank accession num
estriction enzyme site in open reading frame and length of digested DNA fragments
NTPDase Forward primers (F) and reverse
primers (R)
Genbank accession
numbers
PCR pro
1 (rat) F: 5′-GAT CAT CAC TGG GCA
GGA GGA AGG-3′
U81295 542
R: 5′-AAG ACA CCG TTG AAG
GCA CAC TGG-3′
1 (mouse) F: 5′-GGC TGT GAT AGC TTT G-3′ AF037366 763
R: 5′-AGC ATG GGT CCT TAA G-3′
3 (rat) F: 5′-GCT ACT TCA AGT CCC A-3′ NM 178106 1103
R: 5′-AAT CAG AAT CCA CTG C-3′
3 (mouse) F: 5′-GCT ACT TCA AGT CCC A-3′ AY714060 1103
R: 5′-AAT CAG AAT CCA CTG C-3′
4 (rat) F: 5′-ATG GGG AGG ATT GGC A-3′ XM 34134 1783
R: 5′-CTT CCT CCA TCC ACA G-3′
4 (mouse) F: 5′-ATG GGG AGG ATT GGC A-3′ NM 026174 1807
R: 5′-CTT CCT CCA TCC ACA G-3′
5 (rat) F: 5′-TCT TGT CTT CCA TGT G-3′ NM199394 1117
R: 5′-GTT CAC TTT CTT TGT G-3′
5 (mouse) F: 5′-TCT TGT CTT CCA TGT G-3′ NMU238636 1117
R: 5′-GTT CAC TTT CTT TGT G-3′
6 (rat) F: 5′-GTT CAT CTA TGT TGC C-3′ AJ277748 1264
R: 5′-GGG AGT CGA TGT AAT G-3′
6 (mouse) F: 5′-GTT CAT CTA TGT TGC C-3′ NM 172117 1264
R: 5′-GGG AGT CGA TGT AAT G-3′Letters 420 (2007) 6–11 7
roducing unique fragment patterns for each NTPDase. Table 1
ummarizes all relevant information regarding PCR analysis of
TPDases 1 and 3–6.
For amplification of NTPDase 1, Turbo-Pfu (Fermentas, St.
eon-Rot, Germany) was used. For amplification of other NTP-
ases,Taq isopolymerase (Qiagen) was used. Reaction mixtures
ontained 2g of cDNA, dNTPs (2.5 mM each), 2lPfu- orTaq
uffer (10×), 2l dimethyl sulfoxide, and forward primer and
everse primer. The total reaction volume was 20l. In prelimi-
ary experiments, annealing temperatures were optimized using
he Biometra T-Gradient thermocycler (Biometra, Go¨ttingen,
ermany). For NTPDase 1, the optimal annealing temperature
as 60 ◦C, for NTPDases 3 and 4 57 ◦C and for NTPDases 5 and
50 ◦C. Elongation was performed for 60 s (fragments <1 kbp)
r 90 s (fragments >1 kbp) at 72 ◦C (35 cycles). Thereafter, a
nal extension for 10 min at 72 ◦C was performed. Following
CR amplification, 5l of loading buffer (5×) were added to
amples, and bands were separated on gels containing 1.5%
garose (mass/vol) for 45 min at 100 V. Bands were visualized by
thidium bromide staining under UV light using the 100 bp and
kbp DNA standard ladders from New England Biolabs (Frank-
urt/Main, Germany). Following visualization, bands were cut
ut from gels, and DNA was isolated using the QIAEX-II kit
Qiagen). Purified DNA was incubated for 2 h at 37 ◦C with
he appropriate restriction enzymes (BsrGI, AccI, SacI, HincII,
ew England Biolabs). Thereafter, digested DNA was separated
n gels containing 2% (mass/vol) agarose and visualized by
thidium bromide staining under UV light.
bers, expected PCR product length, internal restriction enzyme, position of
for NTPDases 1 and 3–6 from rat and mouse
duct length (bp) Internal
restriction
enzyme
Position of restriction
enzyme site in open
reading frame
Length of digested
DNA fragments
(bp, 5′ → 3′)
BsrGI 740/741 302, 239
AccI 377/378 466, 296
SacI 1217/1218 732, 371
SacI 1217/1218 732, 371
HincII 750/751 750, 1033
HincII 750/751 750, 1057
SacI 768/769 446, 671
SacI 768/769 446, 671
HincII 612/613 538, 726
HincII 612/613 538, 726
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Fig. 1. Expression of NTPDase 1. Reverse-transcribed mRNA from B103 cells (A), fibroblasts (C) and Neuro2a cells (E) was amplified by PCR using appropriate
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PRT-deficient cells. For each cell type, PCRs from two independent cDNA pr
roduct (BsrGI) from B103 control cells. (D) Undigested PCR product (PCR) a
n panels B and D.Membranes were prepared as described [11]. SDS-PAGE
nd immunoblotting were performed as described [5]. Pro-
eins were transferred onto nitrocellulose membranes and
robed with NTPDase 1 antibody C92B2 [3] or NTP-
D
w
s
C
ig. 2. Expression of NTPDase 3. Reverse-transcribed mRNA from B103 cells (A),
rimer pairs. Amplified cDNA was separated on agarose gels calibrated with 1 kbp
PRT-deficient cells. For each cell type, PCRs from two independent cDNA prepara
roduct (SacI) from B103 control cells. (D) Undigested PCR product (PCR) and Sa
PCR) and SacI-digested PCR product (SacI) from Neuro2a cells. In panels B, D an
sed on the right side.standard. The bold band represents the 500 bp band. Con, control cells; HPRT,
tions are shown. (B) Undigested PCR product (PCR) and BsrGI-digested PCR
cI-digested PCR product (AccI) from fibroblasts. The 100 bp standard was usedase 2 antibody BZ3B4F [1]. Immunoreactive proteins
ere visualized using the enhanced chemiluminescence
ystem (GE Healthcare). As positive control, we used
hinese hamster ovary (CHO) cell membranes (2g of pro-
fibroblasts (C) and Neuro2a cells (E) was amplified by PCR using appropriate
standard. The bold band represents the 3 kbp band. Con, control cells; HPRT,
tions are shown. (B) Undigested PCR product (PCR) and SacI-digested PCR
cI-digested PCR product (SacI) from fibroblasts. (F) Undigested PCR product
d F, the 1 kbp standard was used on the left side, and the 100 bp standard was
V. Lorenz et al. / Neuroscience Letters 420 (2007) 6–11 9
Fig. 3. Expression of NTPDase 4. Reverse-transcribed mRNA from B103 cells (A), fibroblasts (C) and Neuro2a cells (E) was amplified by PCR using appropriate
primer pairs. Amplified cDNA was separated on agarose gels calibrated with 1 kbp standard. The bold band represents the 3 kbp band. Con, control cells; HPRT,
HPRT-deficient cells. For each cell type, PCRs from two independent cDNA preparations are shown. (B) Undigested PCR product (PCR) and HincII-digested PCR
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roduct (PCR) and HincII-digested PCR product (HincII) from Neuro2a cells.
tandard was used on the right side.
ein per lane) overexpressing either NTPDase 1 or NTP-
ase 2.
The data shown in Figs. 1–5 were reproduced at least three
imes with one given mRNA preparation. Figs. 1–5 (panels A,
and E) show representative PCR results obtained for two
ndependent cDNA preparations.
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ig. 4. Expression of NTPDase 5. Reverse-transcribed mRNA from B103 cells (A),
rimer pairs. Amplified cDNA was separated on agarose gels calibrated with 1 kbp
PRT-deficient cells. For each cell type, PCRs from two independent cDNA prepara
roduct (SacI) from B103 control cells. (D) Undigested PCR product (PCR) and Sac
PCR) and SacI-digested PCR product (SacI) from Neuro2a cells. In panels B, D an
sed on the right side.HincII-digested PCR product (HincII) from fibroblasts. (F) Undigested PCR
nels B, D and F, the 1 kbp standard was used on the left side, and the 100 bp
B103 control cells expressed higher levels of NTPDase 1
542 bp band) than HPRT-deficient B103 cells (Fig. 1A). In
broblasts, NTPDase 1 expression (763 bp band) was relatively
ow, and differences between control and HPRT-deficient cells
ere not clear (Fig. 1C). Restriction enzyme analysis confirmed
hat the correct bands were amplified (302 and 239 bp for rat
fibroblasts (C) and Neuro2a cells (E) was amplified by PCR using appropriate
standard. The bold band represents the 3 kbp band. Con, control cells; HPRT,
tions are shown. (B) Undigested PCR product (PCR) and SacI-digested PCR
I-digested PCR product (SacI) from fibroblasts. (F) Undigested PCR product
d F, the 1 kbp standard was used on the left side, and the 100 bp standard was
10 V. Lorenz et al. / Neuroscience Letters 420 (2007) 6–11
Fig. 5. Expression of NTPDase 6. Reverse-transcribed mRNA from B103 cells (A), fibroblasts (C) and Neuro2a cells (E) was amplified by PCR using appropriate
primer pairs. Amplified cDNA was separated on agarose gels calibrated with 1 kbp standard. The bold band represents the 3 kbp band. Con, control cells; HPRT,
HPRT-deficient cells. For each cell type, PCRs from two independent cDNA preparations are shown. (B) Undigested PCR product (PCR) and HincII-digested PCR
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roduct (PCR) and HincII-digested PCR product (HincII) from Neuro2a cells.
tandard was used on the right side.
103 cells (Fig. 1B) and 466 and 296 bp for mouse fibroblasts
Fig. 1D). The digest for both PCR products was not complete,
xplaining the third band corresponding to the initial PCR prod-
ct. In Neuro2a cells, we also expected to amplify a 763 bp
ragment, but this was not seen (Fig. 1E), even after assess-
ng multiple reaction conditions including different annealing
emperatures, different polymerases and template/primer ratios.
iven the positive results with the other cell lines using the same
rimers and PCR reaction conditions, these data probably reflect
he absence of NTPDase 1 in Neuro2a cells.
We also performed immunoblotting studies with the NTP-
ase 1 antibody C92B2. In NTPDase 1-expressing CHO cells,
e observed the expected bands (data not shown) [17,13]. How-
ver, no specific bands were detected in B103-, Neuro2a- and
broblast cell membranes (data not shown).
We undertook numerous efforts (various primer pairs, two
ifferent polymerases, different annealing temperatures and dif-
erent template/primer ratios) to detect expression of NTPDase
in the various cell types. However, all PCR efforts were
nsuccessful and no specific bands could be amplified. We also
erformed immunoblotting studies with the NTPDase 2 anti-
ody BZ3B4F. While in NTPDase 2-expressing CHO cells, the
xpected band was detected (data not shown) [17,13], no spe-
ific bands were detected in B103-, Neuro2a- and fibroblast cell
embranes (data not shown).
In B103 control cells, strong expression of NTPDase 3 was
een (1103 bp), whereas the enzyme was absent in HPRT defi-
iency (Fig. 2A). In control fibroblasts, we detected a much
tronger NTPDase 3 signal than in HPRT deficiency (Fig. 2C). In
b
o
6
cHincII-digested PCR product (HincII) from fibroblasts. (F) Undigested PCR
nels B, D and F, the 1 kbp standard was used on the left side, and the 100 bp
ontrast, in Neuro2a cells, HPRT deficiency was associated with
ncreased NTPDase 3 expression (Fig. 2E). Restriction enzyme
nalysis confirmed that the correct bands (732 and 371 bp) were
mplified (Fig. 2B, D and F).
Unlike with NTPDases 1 and 3 (Figs. 1 and 2), the expres-
ion pattern of NTPDase 4 was consistent in all three cell lines
tudied. Specifically, expression of NTPDase 4 (1807 bp band
n rat B103 cells and 1783 bp band in mouse fibroblasts and
ouse Neuro2a cells) was much higher in HPRT-deficient cell
ines than in control cell lines (Fig. 3A, C and E). Restriction
nzyme analysis confirmed that the correct bands were amplified
750 bp and 1033 bp fragments for B103 cells and 750 bp and
057 bp fragments for fibroblasts and Neuro2a cells) (Fig. 3B,
and F). Again, we observed incomplete digestion of PCR
ragments.
Similar to the data obtained for NTPDase 4, HPRT defi-
iency was associated with increased expression of NTPDase 5
1117 bp band) relative to control in all three cell lines (Fig. 5A,
and E). The difference in expression was more pronounced
or Neuro2a cells than for B103 cells and fibroblasts. Restric-
ion enzyme analysis confirmed that the correct bands (671 and
46 bp) were amplified (Fig. 5B, D and F).
A heterogeneous picture emerged with respect to NTPDase
expression. In particular, in B103 cells, HPRT deficiency
as associated with a loss of NTPDase 6 expression (1264 bp
and) (Fig. 5A), whereas in Neuro2a cells, NTPDase 6 was only
bserved in HPRT deficiency (Fig. 5C). In fibroblasts, NTPDase
expression was slightly higher in HPRT-deficient cells than in
ontrol cells (Fig. 5B). Restriction enzyme analysis confirmed
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hat the correct bands (538 and 726 bp) were amplified (Fig. 5B,
and F).
Our previous study on the enzymatic analysis of NTPase
ctivity indicated that HPRT deficiency is associated with
hanges in enzyme activity (increase or decrease) and that the
hanges in activity are dependent on the species and the cell type
tudied [11]. Our RT-PCR studies yielded very complex results.
pecifically, in rat B103 cells, HPRT deficiency is associated
ith strongly decreased expression of NTPDases 3 and 6 and
eakly decreased expression of NTPDase 1, but the expression
f NTPDases 4 and 5 is actually increased. Even more strikingly,
n mouse Neuro2a cells, only increases in NTPDase expression
ere observed. In mouse fibroblasts, NTPDase 3 expression
ecreased, whereas NTPDase 4–6 expression actually increased.
hus, our present expression data for individual NTPDase isoen-
ymes confirm the notion that secondary biochemical changes
n HPRT-deficiency are cell type- and species-specific [12,11].
As an explanation for the discrepancies between the NTPase
ctivity reductions in HPRT deficiency for B103- and Neuro2a
ells and the increase in NTPase activity in HPRT deficiency for
ouse fibroblasts on one hand and the complex changes in NTP-
ase expression on the other hand, it is possible that not all of
he PCR-amplified cDNAs are actually translated into function-
lly active NTPDase proteins in intact cells. In fact, dissociations
etween mRNA- and protein expression are commonly observed
n neuronal cells [8,9]. Additionally, the specific activities of
arious NTPDases may differ from each other. Moreover, NTP-
ases differ from each other in their substrate-specificity [13].
nfortunately, the limited sensitivity of the NTPDase 1 and 2
ntibodies and the non-availability of antibodies for NTPDases
–6 did not allow us to further study NTPDase expression at the
rotein level.
Regardless of which precise enzyme actually accounts for the
ubstantial differences in NTPase activity as a consequence of
PRT deficiency [11], our present expression study on a focused
et of candidate target genes clearly shows that NTPDase isoen-
yme expression is highly complex. Our findings point to distinct
unctional roles of individual NTPDase isoforms. These com-
lex changes in NTPDase expression may reflect (insufficient)
ttempts of cells to compensate for the primary alteration of
ucleotide metabolism in HPRT deficiency. Depending on the
verall changes in NTPDase isoenzyme expression and the spe-
ific activities of isoenzymes, the net result may be an increase
r a decrease in NTPDase activity.
Finally, it should be emphasized that our present study was
erformed with rat and mouse cell lines. Given the well-known
pecies-specificity of biochemical changes in HPRT-deficiency
18,2,4,12,11], one has to be cautious with extrapolations to
ND. Accordingly, in future studies, human neuronal cell cul-
ure cell lines will have to be studied.
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